Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-003764
Filing Date
2014-11-14
Accepted
2014-11-14 16:01:06
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 231787
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17532
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17709
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6072
  Complete submission text file 0001493152-14-003764.txt   1858737

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vnth-20140930.xml EX-101.INS 172759
6 XBRL SCHEMA FILE vnth-20140930.xsd EX-101.SCH 22106
7 XBRL CALCULATION FILE vnth-20140930_cal.xml EX-101.CAL 33278
8 XBRL DEFINITION FILE vnth-20140930_def.xml EX-101.DEF 61049
9 XBRL LABEL FILE vnth-20140930_lab.xml EX-101.LAB 133894
10 XBRL PRESENTATION FILE vnth-20140930_pre.xml EX-101.PRE 112794
Mailing Address 401 WARREN ST. SUITE 200 REDWOOD CITY CA 94063
Business Address 401 WARREN ST. SUITE 200 REDWOOD CITY CA 94063 310-477-5811
Vantage Health (Filer) CIK: 0001497130 (see all company filings)

EIN.: 980659770 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55155 | Film No.: 141223852
SIC: 2834 Pharmaceutical Preparations